| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.25 | 0.07 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |